Komorbidität: Anämie und Herzinsuffizienz

Literatur

• 1 Al-Ahmad A, Rand W M, Manjunath G. et al . Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.  J Am Coll Cardiol. 2001;  38 (4) 955-962
  Google Scholar
• 2 Albitar S, Genin R, Fen-Chong M, Serveaux M O, Bourgeon B. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients.  Nephrol Dial Transplant. 1998;  13 (5) 1206-1210
  Google Scholar
• 3 Anand I, McMurray J J, Whitmore J. et al . Anemia and its relationship to clinical outcome in heart failure.  Circulation. 2004;  110 (2) 149-154
  Google Scholar
• 4 Anand I S, Kuskowski M A, Rector T S. et al . Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.  Circulation. 2005;  112 (8) 1121-1127
  Google Scholar
• 5 Androne A S, Katz S D, Lund L. et al . Hemodilution is common in patients with advanced heart failure.  Circulation. 2003;  107 (2) 226-229
  Google Scholar
• 6 Anker S D, Chua T P, Ponikowski P. et al . Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.  Circulation. 1997;  96 (2) 526-534
  Google Scholar
• 7 Anker S D, Haehling S. Inflammatory mediators in chronic heart failure: an overview.  Heart. 2004;  90 (4) 464-470
  Google Scholar
• 8 Bennett C L, Silver S M, Djulbegovic B. et al . Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.  JAMA. 2008;  299 (8) 914-924
  Google Scholar
• 9 Besarab A, Soman S. Anemia management in chronic heart failure: lessons learnt from chronic kidney disease.  Kidney Blood Press Res. 2005;  28 (5 – 6) 363-371
  Google Scholar
• 10 Bolger A P, Bartlett F R, Penston H S. et al . Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.  J Am Coll Cardiol. 2006;  48 (6) 1225-1227
  Google Scholar
• 11 Deswal A, Petersen N J, Feldman A M, Young J B, White B G, Mann D L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).  Circulation. 2001;  103 (16) 2055-2059
  Google Scholar
• 12 Drueke T B, Locatelli F, Clyne N. et al . Normalization of hemoglobin level in patients with chronic kidney disease and anemia.  N Engl J Med. 2006;  355 (20) 2071-2084
  Google Scholar
• 13 Ezekowitz J A, McAlister F A, Armstrong P W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.  Circulation. 2003;  107 (2) 223-225
  Google Scholar
• 14 Felker G M, Gattis W A, Leimberger J D. et al . Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.  Am J Cardiol. 2003;  92 (5) 625-628
  Google Scholar
• 15 George J, Patal S, Wexler D. et al . Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.  Arch Intern Med. 2005;  165 (11) 1304-1309
  Google Scholar
• 16 Gibbs C R, Blann A D, Watson R D, Lip G Y. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.  Circulation. 2001;  103 (13) 1746-1751
  Google Scholar
• 17 Go A S, Yang J, Ackerson L M. et al . Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.  Circulation. 2006;  113 (23) 2713-2723
  Google Scholar
• 18 Griffith G C, Stragnell R, Levinson D C, Moore F J, Ware A G. A study of the beneficial effects of anticoagulant therapy in congestive heart failure.  Ann Intern Med. 1952;  37 (5) 867-887
  Google Scholar
• 19 Hoppe U C. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?.  Clin Res Cardiol. 2007;  96 (4) 196-198
  Google Scholar
• 20 Horwich T B, Fonarow G C, Hamilton M A, MacLellan W R, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.  J Am Coll Cardiol. 2002;  39 (11) 1780-1786
  Google Scholar
• 21 Kalra P R, Bolger A P, Francis D P. et al . Effect of anemia on exercise tolerance in chronic heart failure in men.  Am J Cardiol. 2003;  91 (7) 888-891
  Google Scholar
• 22 Kazory A, Ross E A. Anemia: the point of convergence or divergence for kidney disease and heart failure?.  J Am Coll Cardiol. 2009;  53 (8) 639-647
  Google Scholar
• 23 Komajda M. Prevalence of anemia in patients with chronic heart failure and their clinical characteristics.  J Card Fail. 2004;  10 (1 Suppl) S1-S4
  Google Scholar
• 24 Kosiborod M, Smith G L, Radford M J, Foody J M, Krumholz H M. The prognostic importance of anemia in patients with heart failure.  Am J Med. 2003;  114 (2) 112-119
  Google Scholar
• 25 Levine B, Kalman J, Mayer L, Fillit H M, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.  N Engl J Med. 1990;  323 (4) 236-241
  Google Scholar
• 26 Lipton A J, Johnson M A, Macdonald T, Lieberman M W, Gozal D, Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia.  Nature. 2001;  413 (6852) 171-174
  Google Scholar
• 27 Maggioni A P, Opasich C, Anand I. et al . Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice.  J Card Fail. 2005;  11 (2) 91-98
  Google Scholar
• 28 Mancini D M, Katz S D, Lang C C, LaManca J, Hudaihed A, Androne A S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.  Circulation. 2003;  107 (2) 294-299
  Google Scholar
• 29 Mitchell J E. Emerging role of anemia in heart failure.  Am J Cardiol. 2007;  99 (6B) 15D-20D
  Google Scholar
• 30 Mozaffarian D, Nye R, Levy W C. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE).  J Am Coll Cardiol. 2003;  41 (11) 1933-1939
  Google Scholar
• 31 Murphy C L, McMurray J J. Approaches to the treatment of anaemia in patients with chronic heart failure.  Heart Fail Rev. 2008;  13 (4) 431-438
  Google Scholar
• 32 Naito M, Kawashima A, Akiba T, Takanashi M, Nihei H. Effects of an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitors on burst forming units-erythroid in chronic hemodialysis patients.  Am J Nephrol. 2003;  23 (5) 287-293
  Google Scholar
• 33 Nanas J N, Matsouka C, Karageorgopoulos D. et al . Etiology of anemia in patients with advanced heart failure.  J Am Coll Cardiol. 2006;  48 (12) 2485-2489
  Google Scholar
• 34 Nixon J V. Left ventricular mural thrombus.  Arch Intern Med. 1983;  143 (8) 1567-1571
  Google Scholar
• 35 Okonko D O, Grzeslo A, Witkowski T. et al . Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.  J Am Coll Cardiol. 2008;  51 (2) 103-112
  Google Scholar
• 36 Ponikowski P, Anker S D, Szachniewicz J. et al . Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.  J Am Coll Cardiol. 2007;  49 (7) 753-762
  Google Scholar
• 37 Ronco C, Haapio M, House A A, Anavekar N, Bellomo R. Cardiorenal syndrome.  J Am Coll Cardiol. 2008;  52 (19) 1527-1539
  Google Scholar
• 38 Schwengel R H, Gottlieb S S, Fisher M L. Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure.  Am J Cardiol. 1994;  73 (12) 908-910
  Google Scholar
• 39 Sharma R, Francis D P, Pitt B, Poole-Wilson P A, Coats A J, Anker S D. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.  Eur Heart J. 2004;  25 (12) 1021-1028
  Google Scholar
• 40 Silverberg D S, Wexler D, Blum M. et al . The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.  J Am Coll Cardiol. 2000;  35 (7) 1737-1744
  Google Scholar
• 41 Silverberg D S, Wexler D, Iaina A, Schwartz D. The interaction between heart failure and other heart diseases, renal failure, and anemia.  Semin Nephrol. 2006;  26 (4) 296-306
  Google Scholar
• 42 Silverberg D S, Wexler D, Sheps D. et al . The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.  J Am Coll Cardiol. 2001;  37 (7) 1775-1780
  Google Scholar
• 43 Singh A K, Szczech L, Tang K L. et al . Correction of anemia with epoetin alfa in chronic kidney disease.  N Engl J Med. 2006;  355 (20) 2085-2098
  Google Scholar
• 44 Smilde T D, Damman K HP. et al . Differential associations between renal function and „modifiable” risk factors in patients with chronic heart failure.  Clin Res Cardiol. 2009;  98 (2) 121-129
  Google Scholar
• 45 Szachniewicz J, Petruk-Kowalczyk J, Majda J. et al . Anaemia is an independent predictor of poor outcome in patients with chronic heart failure.  Int J Cardiol. 2003;  90 (2 – 3) 303-308
  Google Scholar
• 46 Tang Y D, Katz S D. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.  Circulation. 2006;  113 (20) 2454-2461
  Google Scholar
• 47 Tanner H, Moschovitis G, Kuster G M. et al . The prevalence of anemia in chronic heart failure.  Int J Cardiol. 2002;  86 (1) 115-121
  Google Scholar
• 48 van der Meer, Voors A A, Lipsic E, Smilde T D, van Gilst W H, van Veldhuisen D J. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.  J Am Coll Cardiol. 2004;  44 (1) 63-67
  Google Scholar
• 49 van Veldhuisen D J, Dickstein K, Cohen-Solal A. et al . Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.  Eur Heart J. 2007;  28 (18) 2208-2216
  Google Scholar
• 50 Weil J, Colin-Jones D, Langman M. et al . Prophylactic aspirin and risk of peptic ulcer bleeding.  BMJ. 1995;  310 (6983) 827-830
  Google Scholar

Dr. med. Felix Mahfoud

Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin

Kirrberger Straße

66421 Homburg/Saar

Phone: 06841/16-23000

Fax: 06841/16-23389

Email: felix.mahfoud@uks.eu